Albertans who want to continue to protect themselves from the COVID-19 virus will have to pay out of pocket for it starting in the fall of 2025, the province announced on Friday.

Cleveland Department of Public Health officials are warning of a “strong likelihood of increased community spread in the ...

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to ...

RESVIA is now authorized for use in adults aged 18–59 years with an increased risk of respiratory syncytial virus-related ...

The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and ...

In a major boost for infant health, the U.S. Food and Drug Administration (FDA) has approved ENFLONSIA (clesrovimab-cfor) , a ...

The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a welcome win.

Rep Kim Schrier, MD, (D-Wash.), said on X yesterday that some of the newly appointed ACIP replacements are anti-vaccine ...

A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization ...

The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial ...

A vaccine targeting a serious respiratory illness that hits infants hard has resulted in a 75 per cent reduction in babies hospitalised with the virus.

Scientists and analysts express concern that the newly appointed members—which include known anti-vaxxers—could relitigate ...